These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6260870)

  • 21. Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
    Kurtz TO; Winston DJ; Hindler JA; Young LS; Hewitt WL; Martin WJ
    Antimicrob Agents Chemother; 1980 Oct; 18(4):645-8. PubMed ID: 6255864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
    Thabaut A; Durosoir JL; Saliou P
    Chemotherapy; 1981; 27 Suppl 1():19-24. PubMed ID: 6265159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of moxalactam and cefoperazone against Streptococcus pneumoniae with differing susceptibilities to penicillin.
    Tarpay MM; Welch DF; Marks MI
    Chemotherapy; 1982; 28(4):261-6. PubMed ID: 6214382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
    Ahonkhai VI; Sierra MF; Cherubin CE; Shulman MA
    J Antimicrob Chemother; 1982 May; 9(5):411-2. PubMed ID: 6284696
    [No Abstract]   [Full Text] [Related]  

  • 25. [Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
    Baumgärtner M; Dickgiesser N; Müller S; Wundt W
    Arzneimittelforschung; 1981; 31(10):1677-81. PubMed ID: 6274361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
    Lang SD; Edwards DJ; Durack DT
    Antimicrob Agents Chemother; 1980 Mar; 17(3):488-93. PubMed ID: 6252831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of treatment with mezlocillin, ampicillin and latamoxef (moxalactam) of experimental group B beta-haemolytic streptococcal meningitis in rabbits.
    Khurana CM; Deddish PA
    J Antimicrob Chemother; 1983 Feb; 11(2):125-33. PubMed ID: 6219981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
    Cherubin CE; Corrado ML; Sierra MF; Gombert ME; Shulman M
    Antimicrob Agents Chemother; 1981 Oct; 20(4):553-5. PubMed ID: 6282200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
    Greenwood D; Eley A; Pearson N; O'Grady F
    J Antimicrob Chemother; 1981 Apr; 7(4):353-62. PubMed ID: 6265424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
    Wise R; Baker S; Livingston R
    Antimicrob Agents Chemother; 1980 Sep; 18(3):369-71. PubMed ID: 6252833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
    Kemmerich B; Lode H; Belmega G; Jendroschek T; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1983 Mar; 23(3):429-34. PubMed ID: 6303213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
    Woolfrey BF; Fox JM; Quall CO
    J Antimicrob Chemother; 1981 Sep; 8(3):205-11. PubMed ID: 6270052
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 Mar; 17(3):516-7. PubMed ID: 6252832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.
    Sakata Y; Boccazzi A; McCracken GH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):213-7. PubMed ID: 6340600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
    Jacobs MR; Kelly F; Speck WT
    Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.